The Leadership Team at AMPRION drives the strategic vision and operational excellence necessary for advancing breakthrough biomarker testing for neurodegenerative diseases like Alzheimer's, Parkinson's, and Lewy Body Dementia. Comprising key executives, the team oversees clinical development, regulatory compliance, and market strategies, ensuring that innovative solutions reach patients effectively while fostering collaboration and growth within the organization.
View all